scispace - formally typeset
H

Haiying Liu

Researcher at Guangzhou Medical University

Publications -  34
Citations -  1542

Haiying Liu is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Primary biliary cirrhosis & Biliary atresia. The author has an hindex of 12, co-authored 33 publications receiving 879 citations. Previous affiliations of Haiying Liu include Second Military Medical University & Yahoo!.

Papers
More filters
Journal ArticleDOI

Exosomes: biogenesis, biologic function and clinical potential

TL;DR: The potential use of exosomes as valuable diagnostic and prognostic biomarkers for their cell-lineage and state-specific contents, and possibilities as therapeutic vehicles for drug and gene delivery are focused on.
Journal ArticleDOI

Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China

TL;DR: Assessment of the prevalence of PBC among the adults referring hospital for annual health check-up in Southern China by screening sera for PBC-specific autoantibodies found a point prevalence rate of 492 Cases per million and 1,558 cases per million for women over 40, a finding similar to prevalence reported in other geographical areas.
Journal ArticleDOI

Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern Mainland China.

TL;DR: The acquisition of newly identified ICEs conferring multiple antibiotic resistance could in part explain the spread of this specific clone among Chinese neonatal isolates and underlines the need for a constant epidemiological surveillance.
Journal ArticleDOI

Epidemiology of invasive group B streptococcal disease in infants from urban area of South China, 2011-2014.

TL;DR: This study gains insight into the spectrum of GBS infection in south China which will facilitate the development of the guidance for reasonable antibiotics usage and will provide evidence for the implementation of potential GBS vaccines in the future.